Open access
Oct 2026
Bridging innate and adaptive immunity: A bispecific SIRPαD1-αPCSK9 fusion protein reprograms macrophages for durable tumor clearance.
Dual targeting synergistically enhances phagocytosis, preserves antigen cross-presentation, and reprograms tumor microenvironment toward an immunostimulatory state, and activates innate and adaptive antitumor immunity.
Cai-Ling Xu, Kai-Cheng Zhou, Xiao-Zhi Hu et al.
· Cell Reports Medicine · 0 citations